Phase II Study of Abraxane Plus Ipilimumab in Patients With Metastatic Melanoma
Clinical trial NCT01827111 · COMPLETED
Trial details
- NCT number
- NCT01827111
- Sponsor
- M.D. Anderson Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-04-25
- Primary completion
- 2020-09-21
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.